DigiNet: Optimizing personalized care for patients with stage IV non-small cell lung cancer (NSCLC) through a digitally connected provider network-analysis plan of a prospective multicenter cohort trial.

Saved in:
Bibliographic Details
Title: DigiNet: Optimizing personalized care for patients with stage IV non-small cell lung cancer (NSCLC) through a digitally connected provider network-analysis plan of a prospective multicenter cohort trial.
Authors: Kästner A; Institute for Community Medicine, Section Epidemiology of Health Care and Community Health, University Medicine Greifswald, Greifswald, Germany., Kron A; National Network Genomic Medicine, University Hospital of Cologne, Cologne, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany., Eilers L; FOM University of Applied Sciences, Essen, Germany., Spier A; Institute of Health Economics and Clinical Epidemiology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Mildenberger V; Institute of Health Economics and Clinical Epidemiology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Simic D; Institute of Health Economics and Clinical Epidemiology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Stock S; Institute of Health Economics and Clinical Epidemiology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Kron F; FOM University of Applied Sciences, Essen, Germany., Scheffler M; National Network Genomic Medicine, University Hospital of Cologne, Cologne, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany., Schillinger G; Federal Association of the AOK, Berlin, Germany., van den Berg N; Institute for Community Medicine, Section Epidemiology of Health Care and Community Health, University Medicine Greifswald, Greifswald, Germany., Wolf J; National Network Genomic Medicine, University Hospital of Cologne, Cologne, Germany. juergen.wolf@uk-koeln.de.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany. juergen.wolf@uk-koeln.de., Hoffmann W; Institute for Community Medicine, Section Epidemiology of Health Care and Community Health, University Medicine Greifswald, Greifswald, Germany.
Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2025 Sep 09; Vol. 151 (9), pp. 244. Date of Electronic Publication: 2025 Sep 09.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1335
DOI:10.1007/s00432-025-06275-x